ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Cutaneous HPV 3, 15, 38, and 76 Do Not Cause SCC of the Skin (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


2) A GWAS of Cutaneous Squamous Cell Carcinoma (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


3) Meta-analysis of Thyroid Cancer Polymorphisms (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


4) ADH1B and ALDH2 and Hepatocellular Carcinoma Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


5) Statin Use and Liver Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


6) Birth Characteristics and Adult Brain Tumors (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


7) Statin Use and Prostate Cancer Aggressiveness (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


8) Circulating 25(OH)D and Prostate Cancer Survival (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


9) Circulating B2M and Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


10) Estrogen Metabolites and Ovarian Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


11) Heme, Dietary Antioxidants, and Colorectal Adenoma Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


12) Coffee and the Risk of Colorectal Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


13) Raw Garlic Consumption and Lung Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


14) What Predicts an Advanced-Stage Diagnosis of Breast Cancer? (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


15) Health Disparities in Local Print News (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


16) Intervention to Increase HPV Vaccination (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


17) Multilevel Screening Mammography Intervention for Latinas (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


18) Informing Future Population Health Interventions (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


19) The New Vital Sign: Where Do You Live? (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


20) Cancer Epidemiologic Research in Understudied Populations (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


21) Cancer Disparities (Cancer Epidemiology, Biomarkers & Prevention) Friday April 1st 2016


22) E-Cigarette Marketing Online: A Systematic Content Analysis of Manufacturers and Retailers (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


23) Childhood Socioeconomic Position and Pubertal Onset: Implications for Breast Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


24) Effects of Surgical vs. Non-Surgical Weight Loss on Mammary Tumor Burden (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


25) Cigarette Tax Revenues and Consumption under Current and Minimum-Price Regimes (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


26) The Association Between Post-Diagnosis Health Behaviors and Quality of Life in Survivors of Ductal Carcinoma In Situ (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


27) Neighborhood Socioeconomic Deprivation and Geographic Heterogeneity of Tobacco Environment in Missouri (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


28) Active Tobacco Smoke and Environmental Tobacco Smoke Exposure During Potential Biological Windows of Susceptibility in Relation to Breast Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


29) Influence of Personal Exposure to the Cancer of a Loved One on the Breast Cancer Prevention Decisions of High Risk Women (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


30) Dietary Adequacy among Tobacco User Households in Bangladesh (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


31) Hormone Contraception before the First Birth and Ovarian Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


32) Association Between Post-Cancer Diagnosis Dietary Inflammatory Potential and Survival in WHI Observational Study and Dietary Modification Trial (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


33) Perspectives from Healthcare Providers and Women about Completing Human Papillomavirus (HPV) Self-Testing at Home (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


34) HPV Infection among Sexual Minority Women: Does it Matter How Sexual Orientation Is Measured? (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


35) Pancreatic Cancer: Associations of Inflammatory Potential of Diet, Cigarette Smoking, and Long-Standing Diabetes (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


36) Pre- and Post-Diagnostic Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Cancer Survival in Seattle Colon Cancer Family Registry (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


37) Patient Navigation Associated with Decreased 30-Day All-Cause Readmission (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


38) How Have Breast Cancer Screening Intervals Changed Since the 2009 USPSTF Guideline Update? (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


39) Hepatitis Virus and Risk of Pancreatic Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


40) Race, Cholesterol, and Prostate Cancer Recurrence (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


41) Germline Wnt/{beta}-Catenin Pathway Variants and CRC Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


42) Glycemic Index and Lung Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


43) Factors Associated with Biomarkers of Systemic Inflammation (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


44) Estimating Cumulative Risk of Screening Outcomes (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


45) Metformin and Cervical Cancer-Specific Mortality (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


46) Associations between Fatty Acids and Adenomas (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


47) Serum Cytokines, Race, and Lung Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


48) Explaining the Prognosis of Screening-Exposed Breast Cancers (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


49) Accuracy of Protein and RNA-Based Breast Cancer Subtyping (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


50) Intraprostatic Inflammation during Finasteride Treatment (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


51) Impact of Screening on Breast Cancer Mortality (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


52) Exomic Variants Associated with Ovarian Cancer Survival (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


53) IGF1R in Endometrial Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


54) miRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma (Cancer Epidemiology, Biomarkers & Prevention) Friday March 4th 2016


55) Conflating Colorectal Cancer Screening and Diagnostic Testing--Letter (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


56) One-Carbon Metabolism Nutrients and Pancreatic Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


57) Fecal Microbiome in Epidemiologic Studies (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


58) Circulating DNA and Survival in Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


59) Promoting Physical Activity (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


60) Arsenic Metabolism Phenotypes (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


61) Lifestyle Exposures and Telomere Length (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


62) Family History of Cancer and Risk of Breast Cancer Subtypes (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


63) Breast Cancer Risk Prediction Using Clinical Models and SNPs (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


64) Predictors of Human Papillomavirus Vaccination in Males (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


65) Time to Colonoscopy Follow-Up (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


66) ADAMTS5 Polymorphisms and AFB1-Related HCC (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


67) Variants Associated with Mammographic Density in Asian Women (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


68) Calcium and Gut Barrier Function (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


69) Geographic Factors and HPV Vaccination Initiation (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


70) Sleep Insufficiency and Prostate Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


71) Endotoxins and Flagellin and Risk of Colorectal Cancer (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


72) Consensus on Allergies and Glioma (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


73) Adolescent Vaccination Cycles (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


74) Disparities in HL Survival (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


75) Trends in Prostate Cancer Incidence (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


76) Cancer in Appalachia, 2004-2011 (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


77) Exercise and the IGF Axis in Oncology (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


78) The Relationship between Breast and Well-Differentiated Thyroid Cancers (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


79) Sholom Wacholder: In Memoriam (1955-2015) (Cancer Epidemiology, Biomarkers & Prevention) Friday February 5th 2016


80) Job Talks and Interviews (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


81) Risk Analysis of Prostate Cancer in PRACTICAL Consortium--Response (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


82) Risk Analysis of Prostate Cancer in PRACTICAL Consortium--Letter (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


83) Reproductive Factors and Multiple Myeloma (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


84) Tamoxifen and Longitudinal Mammographic Density Change (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


85) Cancer Predisposition Gene Mutations and Pancreatic Cancer (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


86) Statin Use and Breast Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


87) Cross-Cancer Association Analysis of DNA Repair Genes (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


88) NPC GWAS Follow-up Identifies CLPTM1L/TERT Locus (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


89) Aspirin Effects on 2-Hydroxyglutarate (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


90) U.S. Non-Hodgkin Lymphoma Subtype-Specific Mortality Trends (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


91) HPV-Associated Oropharyngeal Cancer in Southern Chinese (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


92) Depression, Antidepressant Use, and Breast Cancer (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


93) Estrogen Exposure and Risk of MPN (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


94) The Heritability of Breast Cancer in NorTwinCan (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


95) Long-Term Impact of FIT Screening on CRC Incidence (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


96) Biomarkers of Acrylamide and Ovarian Cancer Risk in EPIC (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


97) Confounding Radiation Exposure from CT Scans and Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


98) Estrogen Mediation of Body Mass Index-Breast Cancer Risk (Cancer Epidemiology, Biomarkers & Prevention) Wednesday January 13th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()